Tempus Wealth Planning’s GSK GSK Stock Holding History

Tempus Wealth Planning’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$239K	Hold	4,568	–	–	0.05%	255
2026 Q1	$252K	Hold	4,568	–	–	0.06%	237
2025 Q4	$224K	Sell	4,568 -360	-7%	-$16.8K	0.05%	259
2025 Q3	$213K	Buy	+4,928	New	+$192K	0.05%	264
2024 Q4	–	Sell	-5,629	Closed	-$230K	–	256
2024 Q3	$230K	Hold	5,629	–	–	0.08%	201
2024 Q2	$217K	Hold	5,629	–	–	0.09%	187
2024 Q1	$241K	Hold	5,629	–	–	0.11%	174
2023 Q4	$209K	Sell	5,629 -48	-0.8%	-$1.72K	0.09%	184
2023 Q3	$206K	Sell	5,677 -1,280	-18%	-$45.4K	0.1%	156
2023 Q2	$248K	Sell	6,957 -12,288	-64%	-$441K	0.11%	157
2023 Q1	$685K	Sell	19,245 -86	-0.4%	-$3.01K	0.33%	77
2022 Q4	$679K	Buy	+19,331	New	+$644K	0.41%	75
2022 Q3	–	Sell	-14,062	Closed	-$765K	–	181
2022 Q2	$765K	Sell	14,062 -912	-6%	-$50.3K	0.63%	45
2022 Q1	$815K	Sell	14,974 -2,545	-15%	-$138K	0.58%	48
2021 Q4	$966K	Buy	17,519 +11,653	+199%	+$606K	0.52%	57
2021 Q3	$280K	Buy	5,866 +160	+3%	+$8.04K	0.16%	130
2021 Q2	$284K	Buy	5,706 +140	+3%	+$6.73K	0.19%	124
2021 Q1	$248K	Buy	5,566 +480	+9%	+$21.8K	0.26%	86
2020 Q4	$234K	Sell	5,086 -2,400	-32%	-$110K	0.3%	64
2020 Q3	$352K	Sell	7,486 -160	-2%	-$8.02K	0.51%	45
2020 Q2	$390K	Hold	7,646	–	–	0.58%	33
2020 Q1	$362K	Sell	7,646 -260	-3%	-$13.9K	0.59%	30
2019 Q4	$464K	Buy	+7,906	New	+$440K	0.41%	37

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Tempus Wealth Planning's GSK Position: Q2 2026 in Review

Tempus Wealth Planning held its GSK (GSK) position steady in Q2 2026 at 4,568 shares worth $239K. The position accounts for 0.05% of the portfolio, ranked #255.

Tempus Wealth Planning first reported a position in GSK in Q4 2019 and has held it in 23 quarters since. The position peaked at $966K in Q4 2021. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Tempus Wealth Planning held 4,568 shares of GSK worth $239K as of Q2 2026.
Tempus Wealth Planning left its GSK share count unchanged in Q2 2026.
GSK made up 0.05% of Tempus Wealth Planning's portfolio in Q2 2026, its #255 holding.
Tempus Wealth Planning first reported a position in GSK in Q4 2019 and has held it in 23 quarters since.
Tempus Wealth Planning's GSK position peaked at $966K in Q4 2021.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Tempus Wealth Planning's 13F filing for Q2 2026, filed 22 Jul 2026.